Currently under investigation to study the elimination of biofilm infections on prosthetic knee implants during early intervention procedures while maintaining the current standard of care.

  • Granted FDA Breakthrough Device Designation for products that may provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions
  • In vivo animal and in vitro lab studies demonstrated up to 99.6% effectiveness in killing biofilms, including drug-resistant bacteria such as MRSA, E. Coli, etc.
  • May help retain the original implant
  • BioPrax is easy to use – requires minimal training
  • Minimally invasive procedure

Implant Bacterial Biofilm Infections - a Transformational Treatment

The BioPrax Platform

How it targets and eliminates biofilm infections:

A needle is inserted through the skin until the system indicates physical contact with the metal implant

Simplistic touchscreen interface is used to initiate and monitor treatment

Low voltage energy is sent through the implant to create an electrochemical reaction that eliminates biofilms from the implant surface

Once treatment is complete, doctors will continue with the standard of care



Laboratory studies have shown a 99.6% effective elimination of bacterial biofilms including drug-resistant bacteria such as MRSA, E. coli, VRE, MSSA, S. epidermidis, and P. aeruginosa*

*Device is currently under investigation

Learn more about the team that is leading this breakthrough development program

Our Team

Stay up to date on our latest developments as we strive to change the world, one patient at a time.